Ho hlahloba dopamine moputso oa litsela ho ADHD: ho ameha kalapetlele. (2009)

Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newkid JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM.

Setsi sa Naha sa Tlhekefetso ea Lithethefatsi, 6001 Executive Blvd, Kamore ea 5274, MSC 9581, Bethesda, MD 20892, USA. [imeile e sirelelitsoe]

Erratum ho JAMA. 2009 Oct 7; 302 (13): 1420.

inahaneloang

TLHOKOMELISO:

Attention-deficit / hyperactivity disorder (ADHD) -e khetholloang ke matšoao a ho se tsotelle le ho se ts'oenyehe ka matla-ke boloetse bo atileng ka ho fetisisa bongoaneng ba bongoana bo atisang ho phehella ho ba motho e moholo, 'me ho na le bopaki bo ntseng bo eketseha ba khaello ea tšusumetso mofuteng ona.

MORERO:

Ho lekola metheo ea likokoana-hloko e ka bakang khaello ea moputso / tšusumetso ka ho nahana likarolo tsa bohlokoa tsa tsela ea moputso oa boko dopamine (mesoaccumbens).

TŠEBELETSO, HO HLOKA LE BATHO BA SEBELETSO:

Re sebelisitse positron emission tomography ho lekanya matšoao a dopamine synaptic (ba tsamaisang thepa le D (2) / D (3) receptors ho 53 batho ba baholo ba sa ngolisoang ba nang le ADHD le 44 li-control tse ntle pakeng tsa 2001-2009 ho Brookhaven National Laborator.

LITLHAHISO TSE LING TSA HO FUMANA:

Re lekantsitse tlamo e khethehileng ea positron emission tomographic radioligands bakeng sa batsamaisi ba dopamine (DAT) re sebelisa [(11) C] cocaine le li-receptors tsa D (2) / D (3) tse sebelisitsoeng e le bokhoni ba ho kopanya (ho tsamaisoa) tekanyo ea palo -11).

LIKOTSO:

Bakeng sa li-ligand ka bobeli, lipalo tsa limmapa tsa lipalo li bonts'itse hore ho tlama ho khetheha ho ne ho le tlase ho ADHD ho feta ho taolo (moeli oa bohlokoa o behiloeng ho P <.005) libakeng tsa tsela ea moputso oa dopamine ka lehlakoreng le letšehali la boko. Litlhahlobo tsa tikoloho ea lithahasello li netefalitse liphetho tsena. Se boleloang (95% karohano ea kholiseho [CI] ea phapang e bolelang) bakeng sa DAT ho li-nucleus accumbens bakeng sa taolo e ne e le 0.71 vs 0.63 bakeng sa ba nang le ADHD (95% CI, 0.03-0.13, P = .004) le bohareng ba boroko bakeng sa taolo e ne e le 0.16 vs 0.09 bakeng sa ba nang le ADHD (95% CI, 0.03-0.12; P <kapa = .001); bakeng sa li-receptor tsa D (2) / D (3), li-accumbens tse bolelang taolo e ne e le 2.85 vs 2.68 bakeng sa ba nang le ADHD (95% CI, 0.06-0.30, P = .004); 'me bohareng ba bohare, e ne e le bakeng sa taolo ea 0.28 vs 0.18 bakeng sa ba nang le ADHD (95% CI, 0.02-0.17, P = .01). Tlhatlhobo e boetse e netefalitse liphapang ho caudate ea leqele: se boleloang ke DAT bakeng sa taolo e ne e le 0.66 vs 0.53 bakeng sa ba nang le ADHD (95% CI, 0.04-0.22; P = .003) le moelelo D (2) / D (3) bakeng litsamaiso e ne e le 2.80 vs 2.47 bakeng sa ba nang le ADHD (95% CI, 0.10-0.56; P = .005) le liphapang tsa D (2) / D (3) sebakeng sa hypothalamic, ka taolo e nang le moelelo oa 0.12 vs 0.05 bakeng sa ba nang le ADHD (95% CI, 0.02-0.12; P = .004). Lintlha tsa tlhokomelo li amana le D (2) / D (3) ho li-accumbens (r = 0.35; 95% CI, 0.15-0.52; P = .001), midbrain (r = 0.35; 95% CI, 0.14-0.52; P = .001), caudate (r = 0.32; 95% CI, 0.11-0.50; P = .003), le hypothalamic (r = 0.31; CI, 0.10-0.49; P = .003) libaka le ka DAT ho midbrain (r = 0.37; 95% CI, 0.16-0.53; P <kapa = .001).

QETELLO:

Phokotso ea matšoao a dopamine synaptic a amanang le matšoao a ho se tsotelle a bontšitsoe tseleng ea moputso oa dopamine ea barupeluoa ba nang le ADHD.


Attention-deficit / hyperactivity disorder (ADHD) e tšoauoa ka matšoao a ho se tsotelle, khatello ea maikutlo, kapa ho ts'oaroa ho hlahisang ho senyeha ho pholletsa le libaka tsa kelello, boits'oaro le boits'oaro.1 Le ha e le ka lilemo tse ngata ho ne ho lumeloa hore ke bokuli ba bongoana le bohlankana, joale e se e amoheloa le hona ho ba motho e moholo. Ho hakanngoa hore ADHD e ama 3% ho 5% ea baahi ba baholo ba US,2 e etsang hore e be e 'ngoe ea mafu a mafu a kelello a atileng haholo.

Tlhahlobo ea liphatsa tsa lefutso le tikoloho e amang dopamine ea neurotransmitter e se e hlahisitsoe bakeng sa ADHD.3 Boithuto ba liphatsa tsa lefutso bo thathamisitse liphatsa tse 'maloa tsa lefutso tse amanang le ADHD,' me tse nang le mefuta e mengata ka ho fetisisa ea 2 dopamine (mohlala, DRD4 'me DAT 1 liphatsa tsa lefutso),3 le lithuto tsa tikoloho li sibolotse lintlha tsa bohlokoa tsa kotsi tse seng liphatsa tsa lefutso (mohlala, ho tsuba ha basali nakong ea kemolo le maemo a lead) le ona a ka amang lits'ebetso tsa dopamine tsa boko.4 Bopaki bo tsoang liphuputsong tsa ho nahana ka bokong bo bontšitse hore boko dopamine neurotransication bo sitisoa ho ADHD5-9 le hore mefokolo ena e ka ba matšoao a mantlha a ho se tsotelle8 le khatello ea maikutlo.9

Ho boetse ho na le tlhokomeliso e eketsehileng ea hore bakuli ba nang le ADHD ba ka ba le moputso le bofokoli ba susumetso.10-12 Le ha e hlalosoa ka tsela e fapaneng lithuto tsa ""ossoss", "deficitis" tse khothalletsang moputso hangata li khetholloa ke phetoho e sa tloaelehang ea boits'oaro bo latelang maemo a moputso le kotlo. Mohlala, bapisoa le bana ba sa tsejoeng, ba nang le ADHD ha ba fetole boits'oaro ba bona maemong a fetohang a meputso.13 The mesoaccumbens dopamine tsela, eo merero e tlohang sebakeng sa karolelano ea methapo (VTA) bohareng ba mpa ho ea ho bokellane ba methapo e kenang ka botebo ho moputso le khothatsong.14 mme e anngoe maikutlo hore e theole moputso le bofokoli bo susumetsang bo bonoang ho ADHD.11,15 Ka sebele lithuto tsa mahlale a morao-rao tse sebelisang matla a matla a matla a matla a matla a matla a matla a fono (fMRI) li bontšitse ts'ebetso ea ts'ebetso ea li-nucleus e fokotsehile ka ts'ebetso ea moputso ho barupeluoa ba nang le ADHD.16,17 Leha ho le joalo, tsebong ea rona ha ho na thuto e lekantseng matšoao a dopamine ka kotloloho tikolohong ea liqoqiso tsa batho ba nang le ADHD.

Motheong oa sena, re tšoaea liphoso tse ngata tseleng ea dopamine e phaphamisitsoeng (e entsoe ka lisele tsa dopamine bohareng ba bo-'mampuli le lipalo tsa bona ho li-accumbens) ho ADHD. Ho leka tlhahiso-leseling ena, re ile ra hlahloba dopamine D2/D3 receptor (dopamine postsynaptic marker) le phumaneho ea DAT (dopamine presynaptic) ho fumaneha libakeng tsena tsa boko ho barupeluoa ba baholo ba 53 ba nang le ADHD (ha ho mohla ho hlalosoang) le 44 e sa amaneng le ADHD e sebelisang positron emission tomography (PET) le ka bobeli [11C] raclopride le [11C] cocaine (D2/D3 receptor le li-radioligand tsa DAT ka tatellano).18,19

METHODA

barupeluoa ba

Monahano oa PET o entsoe Brookhaven National Laboratory le ho hira mamello le mamello ho etsahetse Univesithing ea Duke, Mount Sinai Medical Center le Univesithing ea California, Irvine, ho tsoa 2001-2009. Tumello ea boto ea thuto ea setheo e fumanoe ho tsoa mekhatlong eohle e nkang karolo. Ho ile ha fumanoa tumello e ngotsoeng e tsoang ho barupeluoa bohle ka mor'a hore thuto e ba hlalosetse ka botlalo. Barupeluoa ba ile ba lefuoa ka lebaka la karolo ea bona. Re ithutile bakuli ba ADND ba 53 ba neng ba so ka ba e bala khafetsa (ho kenyeletsoa 20 e hlalositsoeng tlalehong e fetileng ea DAT ea striatal le tokollo ea dopamine6,8) le taolo e phetseng hantle ea 44. Barupeluoa ba nang le ADHD ba ile ba khethoa ho tloha ho fetisetsoa ho lingaka ho ea mananeong a ADHD setsing ka seng.

Ho fokotsa ho ferekanngoa ke ho pepeseha ha lithethefatsi kapa ho senyeha ha lithethefatsi, barupeluoa ba ile ba qheleloa ka thoko haeba ba ne ba kile ba ba le nalane ea ts'ebeliso e mpe ea lithethefatsi (ntle le nicotine) kapa ka liphetho tse ntle tsa skrine ea moriana, kalafo ea pele kapa ea hajoale ka meriana ea psychotropic (ho kenyeletsoa le tse khothatsang), mafu a kelello ( ho hlahlojoa ha axis I kapa II ntle le ADHD), lefu la methapo, maemo a bongaka a ka fetolang ts'ebetso ea bokong (ke hore, pelo, methapo ea pelo, mafu a oncological, kapa autoimmune), kapa ts'itiso ea hlooho e lahlehileng. (> Metsotso e 30). Mekhoa ena e matla ea ho khetholla e kentse letsoho bolelele ba thuto (ho tloha ka 2001 ho isa ho 2009).

Baoki ba babeli ba ile ba buisana le bakuli ho etsa bonnete ba hore Buka ea ho hlahloba le ea Statistical ea Mathata a kelello(Khatiso ea bone)DSM-IV) mekhoa ea tlhahlobo e fihlelletsoe, ho kenyelletsa ho ba teng ha bonyane ba 6 ea matšoao a ho se tsotelle a 9 (a nang le matšoao a 6 kapa a 9 a tšoaeang kapa a sa tsitsang) joalo ka ha a netefalitsoe ka tlhahlobo e hlophisitsoeng ea kelello e hlophisitsoeng ea kelello e sebelisang liphetoho tsa batho ba baholo tsa boits'oaro ba ADHD. Boemo ba Clinical Global Impressions Tekanyetso20 e sebelisitsoe ho lekola ho senyeha hohle. Bakeng sa tlhahlobo ea mafu, barupeluoa ba ADHD ba ile ba hlokoa hore ba atlehe ka tekanyo e tebileng ea 4 kapa ho feta. Ntle le moo, ho ne ho hlokahala bopaki ho tsoa nalaneng ea morupeluoa e mong le e mong hore matšoao a itseng a ADHD a qalile pele ho lilemo tsa 7. Litaolo li ile tsa nkuoa lipapatsong tsa likoranteng tsa lehae, 'me tsa kopana le mekhoa e ts'oanang ea ho khetholla empa e se mekhoa ea ho kenyelletsa tlhahlobo ea lefu la ADHD. Lipehelo li ne li sa kengoe haeba li hlalosa matšoao a ho se tsotelle kapa a khatello ea mali a sitisang mesebetsi ea letsatsi le letsatsi. Lethathamo 1 e fana ka litekanyetso tsa palo ea batho le barupeluoa.

Lethathamo 1

Lethathamo 1

Sebopeho sa Boemo ba Puo le Bohlale ba Barupeluoa

Mehatla ea Clinical

The DSM-IV Lintho tsa ADHD li ile tsa hlahlojoa ho sebelisoa methapo ea matla le bofokoli ba litekanyetso tsa litekanyetso tsa ADHD le tloaelo e tloaelehileng (SWAN), e sebelisang sekala se nepahetseng bakeng sa matšoao (1 ho 3) le sekala se seng se nepahetseng bakeng sa matšoao a fapaneng (−1 to - 3) ho tloha ka tlase ho karolelano ea boholo bo tlase ho isa ho bohareng bo boholo.21 Sena se lumella motho hore a hlahlobe mefuta e felletseng ea ho sebetsa maemong a 2 a ADHD e hlalositsoeng e le boholo ba batho (ke hore, tlhokomelo le tšebetso kapa pono) ho hlahlojoa ho fapana le ho teba ha psychopathology e amanang le ho ba teng ha tlhokomeliso le matšoao a khatello ea maikutlo ho ba nang le ADHD. Lenane bakeng sa lintlha tse ngata tsa SWANis-3 ho 3. Melemo ea psychometric ea tekanyo ea litekanyetso tsa SWAN e phahametse ea litekanyo tsa litekanyo tsa sekhahla sa boleng.22 Litefiso ho SWAN li ile tsa phethoa ho barupeluoa ba 46 ADHD le li-38 taolo mme li sebelisitsoe ho lekola kamano lipakeng tsa likarolo tsena ho bohle ba nkang karolo le mehato ea PET dopamine (Lethathamo 1).

Hape e fumanoe e ne e le mofuta oa nako e telele oa Conners Adult ADHD rating Scale, e fanang ka tlhaiso ea matšoao a ADHD ka sekhahla sa lintlha tsa 4 (ho hang, 0; hanyane feela, 1; haholo, 2; 3). Ho fanoa ka lintlha tse robeli (bongata ba lintlha tse ka khonehang): A, mathata a ho hlokomela / ho hopola (0-36); B, khatello ea kelello / ho se phomole (0-36); C, ho ba le khatello ea maikutlo / khatello ea maikutlo (0-36); D, mathata a boits'oaro (0-18); E, DSM-IV matšoao a sa tsotelleng (0-27); F, DSM-IV matšoao a susumetsang khatello ea maikutlo (0-27); G, DSM-IV kakaretso ea matšoao (0-54); le index ea H, ADHD (0-36).23 Sisteme ena ea litekanyetso e sebelisitsoe haholo maemong a bongaka le lipatlisiso mme e na le sebopeho se thehiloeng hantle sa mabaka, ts'epahala, le ho nepahala (Lethathamo 1).24

Likarolo tsa PET

HR Motorola+ tomograph e sebelisitsoe (Motorola / CTIKnoxville, Tennessee; resolution 4.5 × 4.5 × 4.5 mm botlalo bophara ba halofo-boholo). Li-scans tsa matla li ile tsa qalisoa hang ka mor'a ho kenngoa ka 4 ho 10 mCi ea [11C] raclopride (tšebetso e khethehileng 0.5-1.5 Ci / μM qetellong ea bombardment) le kamora ho kenngoa ka 4 ho 8 mCi ea [11C] cocaine (ts'ebetso e ikhethileng> 0.53 Ci / μmol qetellong ea bomo) mme li fumanoe ka kakaretso ea metsotso ea 60 joalo ka ha ho hlalositsoe pejana.18,19 Ho ile ha fumanoa mali a arohaneng ho lekanya khatello ea batho ba sa fetoheng [11C] raclopride18 le [11C] koae19 inplasma. Forth ke ho ithuta, [11C] cocaine e ile ea khethoa e le radioligand ea DAT hobane ho tlangoa ha eona ka ho khetheha ho khethoa bakeng sa DAT (ho tlangoa ha eona ho thibetsoe ke lithethefatsi tse thibelang DAT empa eseng ka lithethefatsi tse thibelang li-norepinephrine kapa ba tsamaisang serotonin)25; e fana ka mehato ea ho ikatisa ha barupeluoa ba lekoa ka linako tse fapaneng19 'me kinetics ea eona e loketse tlhaiso ea vivo.26 Ntle le moo, sebopeho sa eona se ts'epahala haholo, ho bohlokoa ha ho etsoa lithuto tse ngata tse fapaneng tse tšoanang le tse entsoeng thutong ena.

Tlhahlobo ea Litšoantšo le Lipalopalo

[11C] peisong le morusu [11Litšoantšo tsa C] cocaine li ile tsa fetoloa litšoantšo tsa karolelano ea palo ka ho li qopitsa palo e pharalletseng ea kabo ea pixel ka 'ngoe ebe e e arola ka bongata ba kabo e ka har'a cerebellum. Ho fumana bophahamo ba pokello, libaka tse potolohileng ho li-cerebellar hemispheres li ile tsa nts'oa lifofaneng tsa 2 tse fumanehang −28 mm le −36 mm ho tloha sefofaneng se kopaneng. Ka nako eo libaka tsa "cerebellar" li ne li ka etsoa li-scans tse matla ho fumana lintlha tsa 11 C vs time, eo hammoho le ho kenella ha tracer e sa fetoheng plasma li neng li sebelisoa ho lekanya palo ea pokello ka har'a cerebellum, ho sebelisoa mokhoa oa ho hlaka litšoantšo bakeng sa lits'ebetso tse feto-fetohang.26 B, max/Kd (karolelano ea tekanyo ea distribution1, eo Kd B, max li sebetsa ka mokhoa o sebetsang ho li-vivo moo ho nang le neurotransmitter ea endo native le nonspecific binding) e sebelisitsoeng joalo ka tekanyo ea D2/D3 receptor le ho fumaneha ha DAT.26 Tekanyo B, max/Kd e lekantsoeng ka tsela ena e bitsoa bokhoni bo tlamang, BPND. Ho ne ho boetse ho lekanngoa phetiso ea plasma-to-tishene khafetsa (K1) ka striatum le cerebellum bakeng sa li-radioligand ka bobeli li sebelisa mokhoa oa tlhahlobo ea litšoantšo.26

'Mapa oa lipalopalo tsa Statistical 27 e sebelisitsoe ho lekola liphapang tsa litšoantšo tsa kabo ea boholo ba kabo (bakeng sa bobeli [11C] raclopride le [11C] litšoantšo tsa "cocaine" lipakeng tsa taolo le barupeluoa ba nang le ADHD ntle le khetho ea mantlha ea boko ba anatomical. Bakeng sa sepheo sena, litšoantšo tsa boholo ba kabo ea boholo ba tsona li ile tsa hlophisoa ka mokhoa oa tlhaho oa Montreal Neurological Institute tse fanoeng ka har'a lipampiri tsa 99 tsa lipalo-palo (Setsi sa Wellcome Trust bakeng sa Neuroimaging, London, England) mme ka mora moo se hlophisitsoe hantle ka 16-mm isotropic Gaussian kernel. Mehlala e ikemetseng t Liteko li entsoe ho bapisa liphapang lipakeng tsa lihlopha. Bohlokoa bo thehiloe ho P<.005 (sehlopha se lokisitsoe> li-voxels tse 100) le limmapa tsa lipalo-palo li ne li manehiloe setšoantšong sa sebopeho sa MRI.

Bohlokoa bo fumanoeng ke 'mapa oa lipalopalo tsa lipalo-palo bo ile ba ntlafatsoa le bohloeki bo ikemetseng ba libaka tse thahasellisang bo sebelisang litempele tse fumanehang boitsebisong ba Talairach Daemon.28 Setšoantšo sa 1 e bonts'a sebaka sa tikoloho ea mokoloto se sebelisitsoeng bakeng sa tlhahlobo ena. Phapang ho D2/D3 receptor le ho fumaneha ha DAT li ile tsa hlahlojoa ka mehlala e ikemetseng t liteko (2 tailed).

Setšoantšo sa 1

Setšoantšo sa 1

Mefuta ea Thahasello e sebelisoang ho tlosa D2/D3 Mehato ea Receptor le Dopamine Transporter

Litlatsetso tsa motsotso oa sehlahisoa sa Pearson li sebelisitsoe ho lekola kamano pakeng tsa DAT le D2/D3 li-receptors le boholo ba 2 ba sekhahla sa tekanyetso ea SWAN (tlhokomelo le tšebetso kapa boiketsiso).

Litlhaloso bakeng sa phapang ea bohlokoa bakeng sa mehato ea sephetho1 e ne e le lipalo tsa lipalopalo tsa lipalo-palo tsa lipalo bakeng sa DAT le D2/D3 litšoantšo li ne li lokela ho ba bohlokoa ho P<.005 (sehlopha se lokisitsoe> li-voxels tse 100) 'me liphetho tsa lebatooa li tlameha ho tiisoa ke sebaka se ikemetseng sa lithahasello2; papiso bakeng sa mehato ena e kopaneng e tlameha ho ba bohlokoa ho P<.053; lihlahlobo tsa tlhabollo li ile tsa tlameha ho ba tsa bohlokoa ho P<.006, e ileng ea khethoa ho boloka boemo ba bohlokoa ba kakaretso ea P<.05 e ipapisitse le khalemelo ea Bonferroni bakeng sa libaka tsa 4 le mehato ea kliniki ea 2 (tlhokomelo le tšebetso kapa boits'oaro). Sephutheloana sa lipalo se sebelisitsoeng e ne e le Statview, mofuta oa 5.0.1 (Concepts ea Abacus, Berkeley, California).

Palo ea boholo ba sampole bakeng sa boithuto bona e ne e ipapisitse le lithuto tsa rona tsa pele (ka mehlala e nyane ea sampole) ka DAT6 le D2/D3 li-receptors,8 e senotseng phapano lipakeng tsa lihlopha pakeng tsa lihlopha ka boholo ba phello (karolelano pakeng tsa phapano ea bolele le phokotso e tloaelehileng) pakeng tsa 0.65 le 0.80. Bakeng sa boholo ba phello, ho fihlella matla a bonyane 80% u sebelisa disampole tse ikemetseng t tlhahlobo e nang le boleng ba bohlokoa ba .05 (2), re hloka ho hira litho tse ka bang 40 ka sehlopha ka seng. Mehlala ea mohlala ea 53 e tlang ho ADHD le 44 lihlopheng tsa taolo e lumelletse ho bonts'a phapang e lekantsoeng ea matla ka matla pakeng tsa 88% le 97% ka disampole tse ikemetseng t teko maemong a bohlokoa a .05 (2 sided).

LIPOTSO

Dopamine D2/D3 Receptors

Tlhahlobo ea 'mapa oa lipalopalo tsa lipalopalo tsa [11C] li-ratio tsa tekanyo ea "li-raclopride" li senotse seqoaha sa 1 se nang le D e tlase2/D3 phumaneho ea karolo ea barupeluoa ba ADHD ho feta ho laola ho hemisphere ea. Sehlopha sena se ne se kenyelletsa libaka tsa bokong tsa moputso oa dopamine mopalami oa "ventral caudate", "rubbens", le libaka tsa "midbrain", hammoho le sebaka sa hypothalamic (Setšoantšo sa 2 le eTable fumaneha ho http://www.jama.com). Liphumano tsena li netefalitsoe ke sebaka se ikemetseng sa khahleho, se bonts'ang phapang ea taolo ea ADHD libakeng tse tloheletsoeng ka thoko, bohareng ba bo-'mankhane, caudate, le libakeng tsa hypothalamic (Lethathamo 2). Ho ne ho se na libaka tse neng li phahame ho nka karolo ho barupeluoa ba ADHD ho feta taolong. Ho fapana le K1 mehato ea [11C] raclopride (ho tsamaisoa ha radioligand ho tloha ho plasma ho ea lithong) e ne e sa fapana ka ho qheleloa ka thoko le lihlopha tseo ka bobeli li na le mokhoa oa 0.11 (95% discval [CI], −0.01 to 0.006 maana phapang) kapa sebakeng se setseng sa rubbens le taolo e nang le moelelo oa 0.12 vs moelelo oa 0.11 bakeng sa ba nang le ADHD (95% CI, −0.01 ho 0.005).

Setšoantšo sa 2

Setšoantšo sa 2

Libaka tsa Brain tse Mehato ea Dopamine e neng e le Tlaase ho Barupeluoa ho fapana le ho Laola

Lethathamo 2

Lethathamo 2

Mehato ea Dopamine D2/D3 Receptor le Dopamine Transporter Ho fumanehaa

Dopamine Baeti

Tlhahlobo ea 'mapa oa lipalopalo tsa lipalopalo tsa [11C] litšoantšo tsa karolelano ea koae ea koae li senotse sehlopha se sebakeng se le seng se bontšitsoeng ho [11C] litšoantšo tsa raclopride. Khokahano ena e ne e kenyelletsa libaka tse ka lehlakoreng le letšehali tsa "caudate", "accumbal "," midbrain "le" "" '' me libakeng tsena libaka tse fumanehang li le tlase ho feta tsa karolo ea "ADHD" ho feta (Setšoantšo sa 2 'me eTable). Ho ne ho se na libaka tse neng li phahame ho nka karolo ho barupeluoa ba ADHD ho feta taolong. Sebaka se ikemetseng sa lithahasello se kopantsoe haholo le phokotso ea theko e tlase ea DAT libakeng tse tlohetsoeng ka mpeng, bohareng ba bana le ho qhekella har'a barupeluoa ba nang le ADHD ho feta har'a taolo, empa liphokotso lebatooeng la hypothalamic le ne le sa fapana haholo (Lethathamo 2). Moelelo oa (95% CI bakeng sa phapang e matla) ea K1 mehato ea [11C] cocaine e ne e sa fapana ho caudate ea leqeleng le 0.49 har'a li-control vs 0.48 har'a ba nang le ADHD (95% CI, −0.05 ho 0.03) kapa sebakeng se kaholimo sa 0.49 vs 0.51 har'a ba nang le ADHD (95 % CI, −0.02 ho 0.07).

Litumellano le litekanyetso tsa matšoao a ADHD

Boholo ba tlhokomelo (ho tloha ho SWAN) bo ne bo amana hantle le D2/D3 ho fumaneha ha "receptor" sebakeng se tlohelletsoeng ka letsohong le letšehali (r= 0.35; 95% CI, 0.15-0.52; P=.001), sebopeho se setseng sa maharengr = 0.35; 95% CI, 0.14-0.52; P = .001), ka morao ka ho le letšehali (r = 0.32; 95% CI, 0.11-0.50; P=.003), le sebaka se setseng sa hypothalamic (r= 0.31; 95% CI, 0.10-0.49; P=.003) le ka ho fumaneha ha DAT ho li-midbrain tse setseng (r = 0.37; CI, 0.16, 0.53; P<.001; Setšoantšo sa 3). Hobane lipalo tsa sekhahla sa SWAN li na le sekhahla se nepahetseng (ho tloha 1 ho 3) le matšoao a fapaneng le sekala se seng (ho tloha −1 ho ea ho −3) ho ikamahanya le maemo ho bontša hore litekanyo tsa dopamine li tlase haholo, matšoao a ho se tsotelle . Ha ho letho le amanang le boholo ba tšebetso kapa boiketsetso bo neng bo le bohlokoa.

Setšoantšo sa 3

Setšoantšo sa 3

Regression Slopes Pakeng tsa Dopamine D2/D3 Receptor le Dopamine Transporter Phihlello le Lipalo mabapi le Tlhokomelo

TLHAHO

Tboithuto ba hae bo fana ka bopaki bo lumellanang le pherekano e boletsoeng esale pele tseleng ea tsebaccumbens dopamine ho ADHD. Ka monahano oa PET, theola D2/D3 phumaneho ea li-receptor le tsa DAT ho ba nang le ADHD ho feta sehlopheng sa taolo li ngotsoe libakeng tsa mantlha tsa boko ba 2 bakeng sa moputso le khothatso (accumbens le midbrain).29 E boetse e paka tšitiso ea matšoao a diphamine tsa synaptic ho caudate ho batho ba baholo ba nang le ADHD mme e fana ka bopaki ba pejana ba hore hypothalamus le eona e ka ameha.

E tlase ho feta tloaelehileng D2/D3 ho ba teng ha li-receptor le ho li-DAT libakeng tsa accumbens le midbrain ho ts'ehetsa maikutlo a ho senyeha ha tsela ea moputso oa dopamine ho ADHD.30 Hobane mehato ea bosholu ba moputso ha e ea ka ea lekanngoa, re ka supa feela hore ho senyeha tseleng ea moputso oa dopamine ho ka tlasa bopaki ba kliniki ba likarabo tse sa tloaelehang tsa ho fumana moputso ho ADHD. Khaello ea moputso ho ADHD e tšoauoa ka ho sitoa ho lieha ho khotsofatsa, karabelo e sa nepahalang ho litekanyetso tse itseng tsa tefiso, le khetho bakeng sa meputso e menyenyane e potlakileng ea meputso e meholo e liehileng.31 Tumellanong le karolo ena ea bohlokoa ea bongaka ba ADHD, phuputso ea morao-rao ea FMRI e tlaleha ho fokotseha hoa ts'ebetso ea "ventral striatum" (moo li-nucleus accumbens li leng teng) bakeng sa moputso o potlakileng le o liehang ho barupeluoa ba baholo ba nang le ADHD ha o bapisoa le taolo.17

Thutong ea rona, ea D2/D3 mehato ea li-receptor ho li-accumbens e ne e amana le boholo ba tlhokomelo, e leng se neng se ka tlama tsela ea moputso oa dopamine matšoao a ho se tsotelle ho ADHD. Sena se ka fana ka tlhaloso ea hore na ke hobaneng ha liphoso tse lebisang tlhokomelo ho batho ba nang le ADHD li bonahala haholo mesebetsing e nkoang e le e khahlisang, e pheta-phetoang ebile e se e khahlisang (ke hore, mesebetsi kapa likabelo tse sa putseng hantle haholo).32 Qetellong, hobane palo e tlase ea dopamine D2/D3 li-receptors tse bokellaneng ba nyutlelie li amahantsoe le kotsi e kholo ea tlhekefetso ea lithethefatsi,33 mosebetsi oa kamoso o lokela ho khetha hore na e tlase ho feta tloaelehileng D2/D3 phumaneho ea li-receptor sebakeng sa liqoqiso ho ADHD e baka tlokotsi e phahameng ea tlhekefetso ea lithethefatsi ho bongata bona.34

E tlase D2/D3 receptor le ho fumaneha ha li-midbrain, tse nang le methapo e mengata ea dopamine bokong, ho tsamaellana le liphumano tse tsoang liphuputsong tsa pele tsa monahano oa bana le ba lilemong tsa bocha ba nang le ADHD ea ho ngola tlhekefetso ea mpa.5,35 Sena se ka etsa hore tlhahiso ea dopamine e fokotsehileng e tlalehiloeng ho batho ba baholo ba nang le ADHD8 hobane ho thunya ha methapo ea dopamine bohareng ba mpa ho ikarabella bakeng sa ho lokolla dopamine ho striatum. Ho feta moo, khokahano e mpe lipakeng tsa mats'oao a dopamine bohareng ba bohareng le boholo ba tlhokomelo (DAT le D2 receptors) e fana ka maikutlo a hore ho sa tšoaetsoe matšoao ho tsoa liseleng tsa dopamine ho kanna ha tlatsetsa ho teba ha matšoao a ho se tsotelehe ho ADHD.

E tlase ho feta tloaelehileng D2/D3 li-receptors le ho fumaneha ha DAT ho ADHD ho caudate le tsona li bontšitsoe. Pele lithuto tsa monahano li ne li tlaleha libuka tse nyane tsa caudate36-40 le caudate e sebetsang tlas'a ts'ebetso41,42 ho barupeluoa ba ADHD ha ba bapisoa le taolo. Ka lehlakoreng le leng, liphetho tsa DAT ho striatum (ho kenyelletsa le caudate) li sa lumellane lithutong tsa barupeluoa ba nang le taolo ea ADHD vs, mme lithuto tse ling li tlaleha haholo,43 ba bang ba tlase,6 mme tse ling ha li na phapang.44 Lebaka la (mabaka) a karohano e hlalositsoe kae kae6 mme e ka bonts'a phapang ho li-radiotracers, mekhoa e sebelisitsoeng (radiotracers; PET vs single Photon emission computer tomography), phapang ea litšobotsi tsa bakuli (ho kenyelletsa nalane ea meriana ea pele ho nako; li-comorbidities, le lilemo tsa barupeluoa), le boholo ba sampole, bo fapaneng ho tloha 6 ho 53 (Thutong ena). Liphumano tsena li fapana le tse tlalehiloeng ho bacha ba nang le ADHD, e bonts'itseng D e phahameng2/D3 ho fumaneha ha "receptor" ka har'a letsoho le letšehali (ho kenyelletsa le caudate) ho feta ho batho ba baholo, ho ne ho fetoleloa ho bontša ho haella ha dopamine ho li-receptor tsena.7 Bacha bana ba nang le ADHD, keketseho e kholo ho striatal D2/D3 ho fumaneha ha li-receptor ho ile ha bonoa ho bakuli bao ka nako ea tsoalo ba neng ba e-na le methapo e fokolang ea mali ea khubung, e neng e fetoleloa ho bontša litlamorao tse bohloko tsa khatello ea methapo mosebetsing oa boko ba dopamine.9

Tpele a fumana ho tlalehiloe mona ka tlase ho dopamine D e tloaelehileng2/D3 ho fumaneha ha li-receptor tikolohong ea hypothalamic ea barupeluoa ba ADHD hoa khahla hobane haeba e ka phetoa, e ka fana ka motheo oa neurobiological bakeng sa Co-morbidity e phahameng ea ADHD ka matšoao le matšoao a amanang le hypothalamic pathology45 joalo ka mathata a boroko,46 ho nona haholo kapa botenya47 le likarabo tse sa tloaelehang khatello ea maikutlo.48 Multiple hypothalamic nuclei expression dopamine D2 li-receptors,49 empa tharollo e lekanyelitsoeng ea sekepe sa PET ha e lumelle ho fumana moo ho nang le liphapang lipakeng tsa lihlopha tse etsahetseng teng. E amanang le karolo ea hypothalamus ho ADHD ke mokhatlo oa liphetoho tse bang teng melanocortin-4-receptor (MC4R) gene, e hlahisitsoeng ka li-nucleoth tse 'maloa tsa hypothalamic tse hlahisang botenya, le ADHD.50

Liphetho tsa rona tsa kopano ea tsela ea dopamine tsa dopamine tse nang le matšoao a ho se tsotelle a ADHD li ka ba le bohlokoa ba tleliniki. Mokhoa ona o bapala karolo ea bohlokoa ho matlafatsong le boikopelong ba ho ithuta mekhatlo e khahlisang moputso,51 le karolo ea eona ho ADHD e ts'ehetsa ts'ebeliso ea lipuisano ho ntlafatsa boiketlo ba mesebetsi ea sekolo le mosebetsi ho ntlafatsa ts'ebetso. Ho kenella ka ts'usumetso le ts'usumetso ea maemo a tšohanyetso ho bontšitsoe ho ntlafatsa ts'ebetso ho bakuli ba ADHD.52 Ho boetse ho bontšitsoe meriana e matlafatsang ho eketsa sekhahla sa mosebetsi oa kelello (tšusumetso, thahasello) ka tekanyo ea dopamine e hlahisoang ke lithethefatsi ho striatum.53

sheba mefokolo ea

[11C] Mehato ea Raclopride e susumetsoa ke dopamine ea extracellular (holimo le holimo dopamine, ntle le tlamo ea [11C] moraro ho D2/D3 li-receptors), ka hona bokhoni bo tlamang bo tlase bo ka bonts'a D e tlase2/D3 maemo a receptor kapa tokollo ea dopamine e eketsehileng.54 Leha ho le joalo, morao-rao ha a na monyetla kaha re ne re kile ra tlaleha hore tokollo ea dopamine sehlopheng se ka tlase sa barupeluoa ba rona ba ADHD e ne e le tlase ho feta taolong.8 Hape leha [11Ho tlama ha koae ka cocaine ho li-DAT ha ho anngoe habonolo ke tlholisano le dopamine ea nako e telele,55 Ho fumaneha ha DAT ho bonts'a eseng feela boteng ba lisetinete tsa dopamine empa hape le molumo oa dopamine ea synaptic, hobane DAT up-regates ha li-dopamine tsa synaptic li phahame ebile li theoha ha li-dopamine li le tlase.56 Kahoo ho fumaneha ha theko e tlase ea DAT ho ne ho ka bonts'a lits'oants'o tse fokolang tsa dopamine kapa ho fokotseha ha polelo ea DAT ka dopamine.

Boholo bo tlase haholo ba [11C] raclopride le [11C] cocaine bakeng sa lipheo tsa bona e etsa hore ba tšoanelehe hamolemo ho lekanya libaka tse nang le D e phahameng2/D3 receptor kapa DAT density (ke hore, caudate, putamen, le accumbens) hape ha e na taba le libaka tse nang le maemo a tlase joalo ka hypothalamus le midbrain. Leha ho le joalo, ntle le moeli ona, ho bontšitsoe phapang e kholo libakeng tse qetellang lipakeng tsa taolo le barupeluoa ba nang le ADHD.

Sekhahla se seng sa thuto e ne e le hore mehato ea ho ba le maikutlo a meputso ha e ea etsoa. Kahoo, re ka fana ka litlatsetso feela tsa hore ho fokotseha hoa matšoao a dopamine sebakeng sa accumbens ho ka tlatsetsa khaello ea moputso e tlalehiloeng ho bakuli ba nang le ADHD.

Litšoantšo tsa MRI tsa morphological ha lia ka tsa fumanoa 'me ka hona, haeba phapang ea litheko ho tse nang le ADHD e neng e ka fana ka lebaka la liphumano tsena li ka se fumanehe ho tloha ha ho tlalehiloe liphapang tsa litheko tsa ADHD.36-40 Leha ho le joalo, hore ho ne ho se na phapang ea sehlopha ka mehato ea K1 (ho tsamaisoa ha radiotracer ho tloha plasma ho ea ho tishu) ho striatum, e ka beng e boetse e anngoe ke liphetoho tsa volumetric, e bonts'a hore liphumano tsena li bonts'a ho fokotseha hoa ho fumaneha hoa selemo sa DAT le D2/D3 li-receptors ho fapana le ho fokotsa litheko tsa bophahamo ba karolo e itseng.

Lits'oants'o tse amanang le ho hlaka kapa ho qobelloa le mekhoa ea dopamine ea PET li ne li se bohlokoa, ho neng ho ka supa hore lintlha li tlase 'me ka lebaka leo, kutloisiso ea ho lekana ha mofuta ona e ne e fokola. Ntle le moo e ka bonts'a ho ameha ha libaka tsa pele ho bohlasoa,57 tse neng li ke ke tsa lekanngoa ka li-radioligands tsa PET tsa hona joale; D2/D3 li-receptor le litekanyetso tsa DAT libakeng tse ka pele li tlaase haholo.

Le ha liphumano tsa bohlokoa thutong ena li lekanyelitsoe ho hemisphere e ka letsohong le letšehali, matla a fokolang a lipalo a kanna a ba le tlatsetso ho haelloeng ha phapang e kholo ea ADHD-libakeng tse nepahetseng tsa boko. Ntle le moo, hobane hypotase ea morao-rao ea kelello e ne e haella 'me, tsebong ea rona, ha ho na bopaki bo tiileng bo fumanehang ka har'a lingoliloeng ho tšehetsa hamorao bakeng sa moputso, litlamorao tsa morao-rao li lokela ho hlalosoa e le tsa pele le tse hlokang ho phetoa.

Phuputso ena e ne e sa qaliloe ho lekola ho ameha ha hypopalamic dopamine ho ADHD. Kahoo, sepheo sena ke sa mantlha ebile se hloka ho phetoa. Ho feta moo, lithuto tsa nako e tlang tse etselitsoeng ho lekola hypothalamic pathology ho ADHD le bohlokoa ba eona ba bongaka li lokela ho lekola lefu la ho robala 'me le se ke la khetha ho nka karolo barupeluoa ba batenya, joalo ka thuto ea morao-rao.

Qetellong, liphetho tsena li bonts'a phokotso ea matšoao a dopamine synaptic tseleng ea moputso oa dopamine mopbrain le sebaka sa barupeluoa ba nang le ADHD se neng se kopantsoe le mehato ea tlhokomelo. E boetse e fana ka bopaki ba pele ba ho kenella ha hypothalamic ho ADHD (e tlase ho D tloaelehileng2/D3 ho fumaneha ha receptor).

Boitsebiso bo Eketsehileng

tafoleng

lumela hore baa fokola

Lithuso / Tšehetso: Patlisiso ena e ile ea etsoa ho Brookhaven National Laboratory (BNL) mme e tšehelitsoe ka karolo ke MH66961-02 ho tsoa ho Lenaneo la Lipatlisiso la Intramural la Setsi sa Naha sa Bophelo (NIH), Setsi sa Naha sa Bophelo ba kelello le tšehetso ea litšebeletso ho tsoa Lefapheng la Matla.

Mosebetsi oa Motšehetsi: Mekhatlo ea lithuso ea lichelete ha ea ka ea nka karolo moqopolong le boits'oarong ba thuto pokello, taolo, tlhahlobo, le phetolelo ea datha; le ho lokisa, ho hlahloba, kapa ho amohela sengoloa.

Mongolo o botlaaseng ba leqephe

Menehelo ea Mongoli: Ngaka Volkow o ne a e-na le phihlello e felletseng ea data yohle e ithutoang mme o nka boikarabello ba botsitso ba data le ho nepahala ha tlhahlobo ea data.

Thuto ea thuto le moralo:Volkow, Wang, Wigal, Newcorn, Swanson.

Ho fumana data: Wang, Kollins, Wigal, Newcorn, Telang, Fowler, Pradhan.

Tlhahlobo le tlhaiso-leseling: Volkow, Wang, Kollins, Wigal, Newcorn, Zhu, Logan, Ma, Wong, Swanson.

Ho ngoloa ha mongolo o ngotsoeng ka letsoho: Volkow, Wang, Fowler.

Phetolelo e hlophisitsoeng ea buka e ngotsoeng bakeng sa botho ba bohlokoa ba kelello: Volkow, Wang, Kollins, Wigal, Newcorn, Telang, Zhu, Logan, Ma, Pradhan, Wong, Swanson.

Tlhahlobo ea statistical: Zhu, Wong, Swanson.

Chelete e fumanoeng: Volkow, Wang, Newcorn.

Tsamaiso ea tsamaiso, ea thekenoloji, kapa ea lintho tse bonahalang: Wang, Kollins, Wigal, Telang, Fowler, Ma, Swanson.

Tlhokomelo ea ho ithuta: Wang, Kollins, Wigal, Fowler.

Litlhaloso tsa lichelete: Ngaka Kollins o tlalehiloe a fumana tšehetso ea lipatlisiso, litefiso tsa ho buisana, kapa bobeli ba tsoang mehloling e latelang: Mesebetsi ea litlatsetso ea Adrenex, Otsuka Pharmaceuticals, Shire Pharmaceuticals, NIDA, NIMH, NINDS, NIEHS, EPA. Ngaka Newcorn e tlaleha ho ba moamoheli oa tšehetso ea lipatlisiso ho Eli Lilly le Ortho-McNeil Janssen, o sebetsa e le moeletsi, moeletsi, kapa bobeli ba Astra Zeneca, BioBehahlangual Diagnostics, Eli Lilly, Novartis, Ortho-McNeil Janssen, le Shire hape e le sebui bakeng sa Ortho-McNeil Janssen. Ngaka Swanson o tlalehile ho fumana tšehetso ho tsoa ho Alza, Richwood, Shire, Celgene, Novartis, Celltech, Gliatech, Cephalon, Watson, CIBA, Janssen le McNeil; esale a le libankeng tsa likeletso tsa Alza, Richwood, Shire, Celgene, Novartis, Celltech, UCB, Gliatech, Cephalon, McNeil, le Eli Lilly; e bile ho li-bureaus tsa libui tsa Alza, Shire, Novartis, Cellthech, UCB, Cephalon, CIBA, Janssen le McNeil; mme o buisane le Alza, Richwood, Shire, Clegene, Novarits, Celltech, UCB, Gliatech, Cephalon, Watson, CIBA, Jansen, McNeil le Eli Lilly. Ngaka Wigal o tlalehile hore o fumana tšehetso ho Eli Lilly, McNeil, Novartis le Shire. Ha ho litaba tse ling tse tlalehiloeng tsa lichelete tse tlalehiloeng.

Tlhahisoleseling e 'Ngoe: The eTable E fumaneha http://www.jama.com.

Menehelo e Eketsehileng: Re leboha basebetsi ba latelang ba BNL: Donald Warner bakeng sa ts'ebetso ea PET; David Schlyer le Michael Schueller bakeng sa ts'ebetso ea cyclotron; Pauline Carter, Millard Jayne, le Barbara Hubbard bakeng sa tlhokomelo ea booki; Payton King bakeng sa tlhahlobo ea plasma; le Lisa Muench, Youwen Xu, le Colleen Shea bakeng sa litokisetso tsa radiotracer; le Karen Appelskog-Torres bakeng sa khokahano ea protocol. Re boetse re leboha basebetsi ba Duke Joseph English le Allan Chrisman bakeng sa ho nka karolo le ho etsa tlhahlobo; le mosebeletsi oa NIH Linda Thomas bakeng sa thuso ea bongoli. Re boetse re leboha batho ba ithaopileng bakeng sa lithuto tsena. Ha ho le ea mongoli kapa batho ba amoheloang ea ileng a lefelloa bakeng sa menehelo ea bona ntle le meputso ea bona.

References

1. Polelo ea Seboka sa Naha sa Khokahano ea Nts'etsopele ea Bophelo ba Setsi. J Am Acad Ngoana Litaba tsa kelello. 2000;39(2): 182-193. [E fetotsoe]
2. Dopheide JA, Pliszka SR. Attention-deficit-hyperactivity disorder: ntjhafatso. Pharmacotherapy. 2009;29(6): 656-679. [E fetotsoe]
3. Swanson JM, Kinsborne M, Nigg J, et al. Etiologic subtypes ea hloko-deficit / hyperacaction disorder: menahano ea bokong, liphatsa tsa lefutso le lintlha tsa tikoloho le dopamine hypothesis. Neuropsychol Rev. 2007;17(1): 39-59. [E fetotsoe]
4. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Lits'oants'o tsa likokoana-hloko tsa tikoloho le khaello ea ho fokola ha tlhokomelo ho bana ba US. Boemo ba bophelo ba Environ. 2006;114(12): 1904-1909. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
5. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM. Ho bokellana bo boholo ba "midbrain [18F] ho DOPA ho bana ba nang le bothata ba ho fokola ka lebaka la khatello ea kelello. Am J Psychiatry. 1999;156(8): 1209-1215. [E fetotsoe]
6. Volkow ND, Wang GJ, Newcorn J, et al. Brain dopamine transporter maemong a kalafo le lithethefatsi ba baholo ba nang le ADHD. Nako ea mokokotlo. 2007;34(3): 1182-1190. [E fetotsoe]
7. Lou HC, Rosa P, Pryds O, et al. ADHD: ho fumaneha ha dopamine receptor ho hokahane le khaello ea mali le phallo ea mali a neonatal. Dev Med Ngoana oa Neurol. 2004;46(3): 179-183. [E fetotsoe]
8. Volkow ND, Wang GJ, Newcorn J, et al. Ts'ebetso ea khatello ea maikutlo ea dopamine ho bohlasoa le bopaki ba pele ba ho kenella ha litho tsa matsoho ho batho ba baholo ba nang le bothata ba ho tsepamisa maikutlo / khatello ea kelello. Arch Gen Psychiatry. 2007;64(8): 932-940. [E fetotsoe]
9. Rosa Neto P, Lou H, Cumming P, Pryds O, Gjedde A. Methylphenidate-evoked potentiation of extracellular dopamine bokong ba bacha ba nang le tsoalo pele ho nako. Ann NY Hannah Sci. 2002;965: 434-439. [E fetotsoe]
10. Luman M, Oosterlaan J, Sergeant JA. Tšusumetso ea li-Contingency tsa matlafatso ho AD / HD. Clin Psychol Rev. 2005;25(2): 183-213. [E fetotsoe]
11. Johansen EB, Killeen PR, Russell VA, et al. Tšimoloho ea litlamorao tsa ho matlafatsa tsa ADHD. Behav Brain Funct. 2009;5: 7. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
12. Haenlein M, Caul WF. Ela hloko phokotso ea bofokoli bo nang le khatello ea mali. J Am Acad Ngoana Litaba tsa kelello. 1987;26(3): 356-362. [E fetotsoe]
13. Kollins SH, Lane SD, Shapiro SK. Tlhahlobo ea liteko tsa psychopathology ea bongoana. Psychol Rec. 1997;47(1): 25-44.
14. RA ea bohlale. Bry moputso circry. Neuron. 2002;36(2): 229-240. [E fetotsoe]
15. Sonuga-Barke EJ. Mefuta ea mabaka a ho hloka tlhokomelo / bofokoli ba kelello. Biol Psychiatry. 2005;57(11): 1231-1238. [E fetotsoe]
16. Ströhle A, Stoy M, Delease J, et al. Ho lebella moputso le litlamorao ho banna ba baholo ba nang le tlhokomelo ea bofokoli / khatello ea kelello. Nako ea mokokotlo. 2008;39(3): 966-972. [E fetotsoe]
17. Plichta MM, Vasic N, Wolf RC, et al. Neural hyporesponsiveness le hypereverfulness nakong ea kapele le e liehang ho sebetsoa ha moputso maemong a batho ba baholo ba haelloang ke kelello / khatello ea kelello. Biol Psychiatry. 2009;65(1): 7-14. [E fetotsoe]
18. Volkow ND, Fowler JS, Wang GJ, et al. Ho hlahisa likhato tse pheta-phetoang tsa carbon-11-raclopride e tlamang bokong ba motho. J Nucl Med. 1993;34(4): 609-613. [E fetotsoe]
19. Fowler JS, Volkow ND, Wolf AP, et al. Ho etsa libaka tsa tlama ea koae ka kelellong ea motho le ea matsu ho vivo. Synapse. 1989;4(4): 371-377. [E fetotsoe]
20. Guy W. Clinical Global Impression (CGI) sekhahla. Ho: Rush AJ, MB ea pele, Blacker D, bahlophisi. Bukana ea Mehato ea Psychiatric. Washington, DC: Ho hatisoa ha Psychiatric ea Amerika; 2000.
21. Swanson JM, Deutsch C, Cantwell D, et al. Pherekano ea lefutso le khatello ea kelello e fokotsang tlhokomelo. Clin Neurosci Res. 2001;1: 207-216.
22. DJ e monyane, Levy F, Martin NC, Hay DA. Attention deficit hyperacaction disorder: Tlhahlobo ea Rasch ea sekala sa litekanyetso tsa SWAN [e phatlalalitsoeng marang-rang ka May 20, 2009] Hum Ps. Doi: 10.1007 / s10578-009-0143-z. [Ref Ref Cross]
23. Likonteraka CK. Methapo ea litekanyetso bothateng ba tlhokomelo / khatello ea kelello. J Clinic Psychiatry. 1998;59(suppl 7): 24-30. [E fetotsoe]
24. Conners CK, Erhardt D, Sparrow E. Mehato ea Tekanyetso ea batho ba baholo: North Tonawanda, NY: Multi-Health Systems Inc; 1999.
25. Volkow ND, Fowler JS, Logan J, et al. Carbon-11-cocaine e tlamang e bapisoa le tekanyetso ea subpharmacological le pharmacological. J Nucl Med. 1995;36(7): 1289-1297. [E fetotsoe]
26. Logan J, Fowler JS, Volkow ND, et al. Tlhahlobo ea setšoantšo se khutlisetsang radioligand e tlamang ho latela litekanyo tsa ts'ebetso ea nako e sebelisitsoeng ho lithuto tsa [N-11C-methyl] - (-) - Cocaine PET lithuto tsa batho. J Cereb flow flow Metab. 1990;10(5): 740-747. [E fetotsoe]
27. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ. Limmapa tsa Statistical parametric ho ts'ebetso ea monahano. Hum Brain Mapp. 1995;2: 189-210.
28. Lancaster JL, Woldorff MG, Parsons LM, et al. Mehala ea automata ea Talairach bakeng sa 'mapa oa boko o sebetsang. Hum Brain Mapp. 2000;10(3): 120-131. [E fetotsoe]
29. RA ea bohlale, Rompre PP. Bopola dopamine le moputso. Annu Rev Psychol. 1989;40: 191-225. [E fetotsoe]
30. Sonuga-Barke EJ. Moetso oa tsela oa bobeli oa AD / HD. Neurosci Biobehav Rev. 2003;27(7): 593-604. [E fetotsoe]
31. Tripp G, Wickens JR. Dopamine phetisetso. J Ngaka Psychol Psychiatry. 2008;49(7): 691-704. [E fetotsoe]
32. Barkley RA. Attention Deficit Hyperacaction Disorder: Buka ea Lets'oao ea ho Fumana Boloetse le Phekolo. New York, NY: Koranta ea Guilford; 1990.
33. Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2 / 3 receptors e bolela esale pele hore ho na le tšusumetso e mpe le ho ts'ehetsa k'hok'heine. Saense. 2007;315(5816): 1267-1270. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
34. Elkins IJ, McGue M, Iacono WG. Litlamorao tse ka hlahang tsa ho tsotella / ho ferekanya kelello, ho hloka boitšoaro, thobalano ts'ebelisong ea lithethefatsi le tlhekefetso ea bacha. Arch Gen Psychiatry. 2007;64(10): 1145-1152. [E fetotsoe]
35. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Fokotsa transporter ea "midbrain dopamine" e tlamang bacha ba batona ba nang le tlhokomelo ea bofokoli / khatello ea kelello. Biol Psychiatry. 2005;57(3): 229-238. [E fetotsoe]
36. Castellanos FX, Giedd JN, Marsh WL, et al. Boholo ba matla a khoheli a bokellana ba kelello bo ka rarollang bothata ba khatello ea kelello. Arch Gen Psychiatry. 1996;53(7): 607-616. [E fetotsoe]
37. Filipek PA, Semrud-Clikman M, Steingard RJ, Renshaw PF, Kennedy DN, tlhahlobo ea Biederman J. Volumetric MRI ha a bapisa lithuto tse nang le taolo ea khatello ea kelello le taolo e tloaelehileng. Neurology. 1997;48(3): 589-601. [E fetotsoe]
38. Castellanos FX, Giedd JN, Berquin PC, et al. Bokhoni ba kelello ba ho lekanya matla a tlhaho ho banana ba nang le bothata ba ho tsepamisa maikutlo / khatello ea kelello. Arch Gen Psychiatry. 2001;58(3): 289-295. [E fetotsoe]
39. Lopez-Larson M, Michael ES, Terry JE, et al. Phapang e sa lekanyetsoang har'a bacha ba nang le bothata ba ho tsepamisa maikutlo / khatello ea kelello ha e bapisoa le ba nang le lefu la ho ferekanya kelello le ho hloka tlhokomelo. J Ngwana Adolesc Psychopharmacol. 2009;19(1): 31-39. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
40. Qiu A, Crocetti D, Adler M, et al. Bolo ea basal ganglia le sebopeho sa bana ba nang le khaello ea khatello ea kelello. Am J Psychiatry. 2009;166 (1): 74-82. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
41. Vaidya CJ, Bunge SA, Dudukovic NM, Zalecki CA, Elliott GR, Gabrieli JD. Li-substrates tse fetotsoeng tsa neural tsa taolo ea kelello ho ADHD ea bongoana. Am J Psychiatry. 2005;162(9): 1605-1613. [E fetotsoe]
42. Booth JR, Burman DD, Meyer JR, et al. Mefokolo e meholo marang-rang a boko bakeng sa thibelo ea karabelo ho fapana le ho shebella ka hloko ha u bala tlhokomelo ea tlhaelo-leseling e fokolisang tlhokomelo (ADHD) J Ngaka Psychol Psychiatry. 2005;46(1): 94-111. [E fetotsoe]
43. Spencer TJ, Biederman J, Madras BK, et al. Bopaki bo eketsehileng ba dopamine transporter dysregulation ho ADHD: thuto e laoloang ea PET e sebelisitsoeng e sebelisa altropane. Biol Psychiatry. 2007;62(9): 1059-1061. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
44. van Dyck CH, Quinlan DM, Cretella LM, et al. Ho fumaneha ha dopamine transporter ho fumaneha ha batho ba baholo ba hlokang ho fokola ka lebaka la khatello ea kelello. Am J Psychiatry. 2002;159(2): 309-312. [E fetotsoe]
45. Cortese S, Konofal E, Lecendreux M. Tlhokomeliso le boits'oaro ba ho fepa ka ADHD. Tšoaea liphoso. 2008;71(5): 770-775. [E fetotsoe]
46. Cortese S, Konofal E, Yateman N, Mouren MC, Lecendreux M. Ho robala le ho falimeha ho bana ba nang le khaello ea tlhokomelo / bofokoli ba kelello. Robala. 2006;29(4): 504-511. [E fetotsoe]
47. Waring ME, Lapane KL. Ho nona ho feta tekano baneng le lilemong tsa bocha mabapi le tlhokomelo-nakonyana / khatello ea kelello. Lingaka. 2008;122(1): e1-e6. [E fetotsoe]
48. King JA, Barkley RA, Barrett S. Attention-deficit hyperacaction disc le karabelo ea khatello ea maikutlo. Biol Psychiatry. 1998;44(1): 72-74. [E fetotsoe]
49. Gurevich EV, Joyce JN. Ho tsamaisoa ha dopamine D3 receptor e hlahisang li-neurons phatleng ea motho. Neuropsychopharmacology. 1999;20(1): 60-80. [E fetotsoe]
50. Agranat-Meged A, Ghanadri Y, Eisenberg I, Ben Neriah Z, Kieselstein-Gross E, Mitrani-Rosenbaum S. Attention deficit hyperactivity in obese melanocortin-4-receptor (MC4R) lithuto tse haelloang. Am J Med Genet B Neuropsychiatr Genet. 2008;147B (8): 1547-1553. [E fetotsoe]
51. Letsatsi JJ, Roitman MF, Wightman RM, Carelli RM. Ho ithuta ho kopanetsanang ho fetoha le liphetoho tse matla ho dopamine ho saena ho li-nucleus tsa li-nucleus. Nat Neurosci. 2007;10(8): 1020-1028. [E fetotsoe]
52. Barkley RA. Bacha ba nang le bothata ba ho tsepamisa mohopolo / khatello ea kelello. J Psychiatr Itloaetse. 2004;10(1): 39-56. [E fetotsoe]
53. Volkow ND, Wang GJ, Fowler JS, et al. Bopaki ba hore methylphenidate e ntlafatsa boea ba mosebetsi oa lipalo ka ho eketsa dopamine bokong ba motho. Am J Psychiatry. 2004;161(7): 1173-1180. [E fetotsoe]
54. Gjedde A, Wong DF, Rosa-Neto P, Cumming P. Ho etsa li-neuroreceptors mosebetsing: ka litlhaloso le tlhaloso ea bokhoni bo tlamang kamora lilemo tsa tsoelo-pele ea 20. Int Rev Neurobiol. 2005;63: 1-20. [E fetotsoe]
55. Gatley SJ, Volkow ND, Fowler JS, Dewey SL, Logan J. Sensitivity of striatal [11C] cocaine binding ho fokotseha ho dopamine ea synaptic. Synapse. 1995;20 (2): 137-144. [E fetotsoe]
56. Zahniser NR, Doolen S. Tsamaiso e mpe hape e matla ea ba tsamaisang thepa ba tsamaeang ka Na + / Cl-wate. Pharmacol Ther. 2001;92(1): 21-55. [E fetotsoe]
57. Winstanley CA, Eagle DM, Robbins TW. Mefuta ea boitšoaro bo amanang le ADHD: phetolelo lipakeng tsa lithuto tsa kliniki le tsa preclinical. Clin Psychol Rev. 2006;26(4): 379-395. [Tlhahiso ea mahala ea PMC] [E fetotsoe]